Covered recipient · General Payments record
LISA MARIE GUAN
Eye and Vision Services Providers Optometrist
General Payments · PY2018–2024
$2,896.44
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $459.34 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bausch & Lomb Americas Inc. | $142.92 | 4 |
| ABBVIE INC. | $96.75 | 3 |
| Dompe US, Inc. | $69.51 | 2 |
| Harrow Eye, LLC | $67.55 | 2 |
| Oyster Point Pharma, Inc. | $25.26 | 1 |
| RxSight Inc | $20.27 | 1 |
| Thea Pharma Inc. | $18.71 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.60 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845994 | CMS |
| ABBVIE INC. | $30.14 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845996 | CMS |
| ABBVIE INC. | $33.01 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103845998 | CMS |
| Bausch & Lomb Americas Inc. | $9.02 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140396892 | CMS |
| Bausch & Lomb Americas Inc. | $0.45 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140396886 | CMS |
| Bausch & Lomb Americas Inc. | $9.02 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140396888 | CMS |
| Bausch & Lomb Americas Inc. | $124.43 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140396890 | CMS |
| Dompe US, Inc. | $34.66 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151409705 | CMS |
| Dompe US, Inc. | $34.85 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151409707 | CMS |
| Harrow Eye, LLC | $30.61 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145604246 | CMS |
| Harrow Eye, LLC | $36.94 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145604248 | CMS |
| Oyster Point Pharma, Inc. | $25.26 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147412592 | CMS |
| RxSight Inc | $20.27 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144217674 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.37 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152175181 | CMS |
| Thea Pharma Inc. | $18.71 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074541275 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.